SEC Info - Adaptimmune Therapeutics PLC - ‘8-K’ for 1/13/20

SEC Info℠

Home

Help

Please Sign In

Adaptimmune Therapeutics PLC – ‘8-K’ for 1/13/20 – ‘XML’

On: Monday, 1/13/20, at 8:42am ET · For: 1/13/20 · Accession #: 1104659-20-3256 · File #: 1-37368

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 1/13/20  Adaptimmune Therapeutics PLC      8-K:5,8,9   1/13/20   13:396K                                   Toppan Merrill/FA

Current Report — Form 8-K — Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     36K 
 2: EX-10.1     Material Contract                                   HTML     83K 
 3: EX-10.2     Material Contract                                   HTML     42K 
 4: EX-99.1     Miscellaneous Exhibit                               HTML     15K 
 9: R1          Cover                                               HTML     49K 
 8: XML         IDEA XML File -- Filing Summary                      XML     12K 
10: XML         XBRL Instance -- tm201697d1_8k_htm                   XML     15K 
13: EXCEL       IDEA Workbook of Financial Reports                  XLSX      6K 
 6: EX-101.LAB  XBRL Labels -- adap-20200113_lab                     XML     97K 
 7: EX-101.PRE  XBRL Presentations -- adap-20200113_pre              XML     64K 
 5: EX-101.SCH  XBRL Schema -- adap-20200113                         XSD     13K 
11: JSON        XBRL Instance as JSON Data -- MetaLinks               25±    34K 
12: ZIP         XBRL Zipped Folder -- 0001104659-20-003256-xbrl      Zip     41K

‘XML’ — XBRL Instance — tm201697d1_8k_htm

This Document is an XBRL XML File.

<?xml version="1.0" encoding="windows-1252"?>

<link:schemaRef xlink:href="adap-20200113.xsd" xlink:type="simple"/>

</entity>

</period>

</context>

</unit>

<measure> shares </measure>

</unit>

</unitNumerator>

<measure> shares </measure>

</unitDenominator>

</divide>

</unit>

<dei:EntityCentralIndexKey contextRef="From2020-01-12to2020-01-13"> 0001621227 </dei:EntityCentralIndexKey>

<dei:AmendmentFlag contextRef="From2020-01-12to2020-01-13"> false </dei:AmendmentFlag>

<dei:EntityTaxIdentificationNumber contextRef="From2020-01-12to2020-01-13" id="xdx2ixbrl0014"> 00-0000000 </dei:EntityTaxIdentificationNumber>

<dei:DocumentType contextRef="From2020-01-12to2020-01-13"> 8-K </dei:DocumentType>

<dei:DocumentPeriodEndDate contextRef="From2020-01-12to2020-01-13"> 2020-01-13 </dei:DocumentPeriodEndDate>

<dei:EntityRegistrantName contextRef="From2020-01-12to2020-01-13"> ADAPTIMMUNE THERAPEUTICS PLC </dei:EntityRegistrantName>

<dei:EntityIncorporationStateCountryCode contextRef="From2020-01-12to2020-01-13"> X0 </dei:EntityIncorporationStateCountryCode>

<dei:EntityFileNumber contextRef="From2020-01-12to2020-01-13"> 1-37368 </dei:EntityFileNumber>

<dei:EntityAddressAddressLine1 contextRef="From2020-01-12to2020-01-13"> 60 Jubilee Avenue </dei:EntityAddressAddressLine1>

<dei:EntityAddressAddressLine2 contextRef="From2020-01-12to2020-01-13"> Milton Park </dei:EntityAddressAddressLine2>

<dei:EntityAddressCityOrTown contextRef="From2020-01-12to2020-01-13"> Abingdon, Oxfordshire </dei:EntityAddressCityOrTown>

<dei:EntityAddressPostalZipCode contextRef="From2020-01-12to2020-01-13"> OX14 4RX </dei:EntityAddressPostalZipCode>

<dei:EntityAddressCountry contextRef="From2020-01-12to2020-01-13"> GB </dei:EntityAddressCountry>

<dei:CityAreaCode contextRef="From2020-01-12to2020-01-13"> 44 </dei:CityAreaCode>

<dei:LocalPhoneNumber contextRef="From2020-01-12to2020-01-13"> 1235 430000 </dei:LocalPhoneNumber>

<dei:WrittenCommunications contextRef="From2020-01-12to2020-01-13"> false </dei:WrittenCommunications>

<dei:SolicitingMaterial contextRef="From2020-01-12to2020-01-13"> false </dei:SolicitingMaterial>

<dei:PreCommencementTenderOffer contextRef="From2020-01-12to2020-01-13"> false </dei:PreCommencementTenderOffer>

<dei:PreCommencementIssuerTenderOffer contextRef="From2020-01-12to2020-01-13"> false </dei:PreCommencementIssuerTenderOffer>

<dei:Security12bTitle contextRef="From2020-01-12to2020-01-13"> American Depositary Shares, each representing 6 Ordinary Shares, par value £0.001 per share </dei:Security12bTitle>

<dei:TradingSymbol contextRef="From2020-01-12to2020-01-13"> ADAP </dei:TradingSymbol>

<dei:SecurityExchangeName contextRef="From2020-01-12to2020-01-13"> NASDAQ </dei:SecurityExchangeName>

<dei:EntityEmergingGrowthCompany contextRef="From2020-01-12to2020-01-13"> false </dei:EntityEmergingGrowthCompany>

</xbrl>

7 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 3/06/24  Adaptimmune Therapeutics plc      10-K       12/31/23  131:16M                                    Toppan Merrill Bridge/FA
 4/18/23  Adaptimmune Therapeutics plc      S-4/A                  7:5.6M                                   Toppan Merrill/FA
 4/05/23  Adaptimmune Therapeutics plc      S-4                    7:4.5M                                   Toppan Merrill/FA
 3/06/23  Adaptimmune Therapeutics plc      10-K       12/31/22  117:15M                                    Toppan Merrill Bridge/FA
 3/14/22  Adaptimmune Therapeutics plc      10-K       12/31/21  109:13M                                    Toppan Merrill Bridge/FA
 2/25/21  Adaptimmune Therapeutics plc      10-K       12/31/20  112:13M                                    Toppan Merrill Bridge/FA
 8/10/20  Adaptimmune Therapeutics plc      S-3ASR      8/10/20    5:1.6M                                   Toppan Merrill/FA

↑Top

Filing Submission 0001104659-20-003256 – Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Adaptimmune Therapeutics PLC – ‘8-K’ for 1/13/20 – ‘XML’

On: Monday, 1/13/20, at 8:42am ET · For: 1/13/20 · Accession #: 1104659-20-3256 · File #: 1-37368

Current Report — Form 8-K — Sect. 13 / 15(d) – SEA’34Filing Table of Contents

‘XML’ — XBRL Instance — tm201697d1_8k_htm

This Document is an XBRL XML File.

7 Subsequent Filings that Reference this Filing

Current Report — Form 8-K — Sect. 13 / 15(d) – SEA’34
Filing Table of Contents